Ligne de temps
François Anna
Etudiant(e) en thèse
04 juil. 2025
publication
Optimized lentiviral backbone induces robust and diverse T cell immunity against neoantigens to counteract tumor heterogeneity.
Lire plus10 juin 2024
publication
T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector.
Lire plus07 sept. 2023
publication
Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.
Lire plus21 déc. 2022
publication
Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters
Lire plus14 sept. 2022
publication
A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity.
Lire plus26 juil. 2022
publication
A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunity.
Lire plus27 avr. 2022
publication
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.
Lire plus07 déc. 2021
publication
Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.
Lire plus29 juil. 2021
26 juil. 2021
news
Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France
Lire plus02 sept. 2020
publication